Patents Assigned to Cipher Pharmaceuticals Inc.
  • TREATMENT OF CONNECTIVE TISSUE DISEASES OF THE SKIN
    Publication number: 20190125699
    Abstract: The present invention provides effective and safe medicaments for the treatment of connective tissue diseases of the skin, particularly with respect to the treatment of cutaneous forms of Lupus Erythematous. The medicaments comprise as the therapeutically active ingredient a beta2 adrenoceptor agonist. The invention furthermore relates to dermatological compositions without skin sensitization properties and which contain enantiomerically pure or enriched R-enantiomers of a beta2 adrenoceptor agonist.
    Type: Application
    Filed: December 21, 2018
    Publication date: May 2, 2019
    Applicant: CIPHER PHARMACEUTICALS INC.
    Inventors: Morten Sloth WEIDNER, Hans Christian WULF
  • Treatment of connective tissue diseases of the skin
    Patent number: 9907765
    Abstract: The present invention provides effective and safe medicaments for the treatment of connective tissue diseases of the skin, particularly with respect to the treatment of cutaneous forms of Lupus Erythematous. The medicaments comprise as the therapeutically active ingredient a beta2 adrenoceptor agonist. The invention furthermore relates to dermatological compositions without skin sensitization properties and which contain enantiomerically pure or enriched R-enantiomers of a beta2 adrenoceptor agonist.
    Type: Grant
    Filed: February 23, 2017
    Date of Patent: March 6, 2018
    Assignee: Cipher Pharmaceuticals Inc.
    Inventors: Morten Sloth Weidner, Hans Christian Wulf